Overview
Satoshi Owada practices practicing medicine in Isehara, Japan.
His clinical expertise encompasses Cerebral Hypoxia, Pancreatic Cancer, Ganglion Cyst, and Liver Cancer.
He is actively involved in clinical research, co-authoring 15 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Satoshi Owada
Is Satoshi Owada a top-rated expert for Cerebral Hypoxia?
MediFind is an objective health platform that identifies experts based on real-world data. Satoshi Owada is classified as an Experienced expert for Cerebral Hypoxia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Satoshi Owada participate in research or clinical trials?
Yes. Satoshi Owada has published 15 articles and abstracts on conditions like Cerebral Hypoxia. You can view a list of Satoshi Owada's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cerebral HypoxiaMr. Owada isExperienced. Learn about Cerebral Hypoxia.
- Ganglion CystMr. Owada isExperienced. Learn about Ganglion Cyst.
- Liver CancerMr. Owada isExperienced. Learn about Liver Cancer.
- Pancreatic CancerMr. Owada isExperienced. Learn about Pancreatic Cancer.